Short communicationRepeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain
References (28)
- et al.
Human leukocyte interferon (HulFN-α): potent endorphin-like opioid activity
Biochem. Biophys. Res. Commun.
(1981) - et al.
Does the immune system communicate with the central nervous system? Interferon modifies central nervous activity
J. Neuroimmunol.
(1985) - et al.
Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by nolozone
Neuropharmacology
(1990) - et al.
The biological basis for clinical use of interferon
J. Hepatol.
(1990) - et al.
Interferons with special emphasis on the immune system
Adv. Immunol.
(1983) - et al.
Interferon-related mental deterioration and behavioral changes in patients was renal cell carcinoma
Eur. J. Cancer
(1990) - et al.
Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities
J. Neurooncol.
(1988) - et al.
Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer
JAMA
(1984) - et al.
Biochemical hypotheses of mood and anxiety disorders
- et al.
Neurophysiological effects of recombinant interferon-gamma and -alpha in man
Clin. Physiol. Biochem.
(1989)
Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines
J. Pharmacol. Exp. Ther.
(1966)
Dopamine and depression
J. Neurol. Transm.
(1993)
Behavioral effects of mouse interferon-α and -γ and human interferon-α in mice
Brain Res.
(1992)
Mechanisms of fever induced by recombinant human interferon
J. Clin. Invest.
(1984)
Cited by (146)
Microbes and Parkinson's disease: from associations to mechanisms
2022, Trends in MicrobiologyPeripheral inflammation induces long-term changes in tyrosine hydroxylase activation in the substantia nigra
2021, Neurochemistry International
Copyright © 1997 Published by Elsevier B.V.